Beam Therapeutics Inc. short interest in 2023
In 2023, Beam Therapeutics Inc.'s disclosed short interest ran from 18.46% of shares outstanding on 13 Jan 2023 to 16.55% on 29 Dec 2023, a change of -1.91 percentage points. The year's high was 19.74% on 15 Mar 2023 and its low 15.74% on 31 Jul 2023, averaging 17.35% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.63 days on 31 Aug 2023. Full history: Beam Therapeutics Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 18.46% (13 Jan 2023)
- End of year
- 16.55% (29 Dec 2023)
- Change
- -1.91 pp
- High
- 19.74% (15 Mar 2023)
- Low
- 15.74% (31 Jul 2023)
- Average
- 17.35%
- Highest days to cover
- 19.63 (31 Aug 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 18.46% | 15.23 | results (8-K) |
| 31 Jan 2023 | 17.62% | 18.92 | |
| 15 Feb 2023 | 16.95% | 14.09 | |
| 28 Feb 2023 | 17.71% | 13.56 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 19.74% | 11.49 | |
| 31 Mar 2023 | 19.31% | 13.72 | |
| 14 Apr 2023 | 18.27% | 13.40 | |
| 28 Apr 2023 | 18.07% | 16.38 | |
| 15 May 2023 | 17.26% | 14.22 | 10-Q filed, results (8-K) |
| 31 May 2023 | 16.42% | 15.24 | |
| 15 Jun 2023 | 16.34% | 18.69 | |
| 30 Jun 2023 | 16.57% | 14.00 | |
| 14 Jul 2023 | 16.35% | 14.75 | |
| 31 Jul 2023 | 15.74% | 14.40 | |
| 15 Aug 2023 | 16.49% | 13.31 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 16.58% | 19.63 | |
| 15 Sep 2023 | 17.06% | 14.02 | |
| 29 Sep 2023 | 18.12% | 16.85 | |
| 13 Oct 2023 | 19.06% | 17.08 | |
| 31 Oct 2023 | 18.25% | 9.17 | |
| 15 Nov 2023 | 16.96% | 7.67 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 15.95% | 8.18 | |
| 15 Dec 2023 | 16.53% | 11.01 | |
| 29 Dec 2023 | 16.55% | 8.95 |
See also: Beam Therapeutics Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.